Upgrades and Downgrades for Monday, 9/23

Upgrades

  • Consolidated Edison (ED) upgraded by KeyBanc from Sector Weight to Overweight
  • easyJet (ESYJY) upgraded by HSBC from Hold to Buy
  • AIB Group (AIBRF) upgraded by BofA/Merrill from Underperform to Neutral
  • Telefonica Deutschland (TELDF) upgraded by Credit Suisse from Underperform to Neutral
  • Atos (AEXAY) upgraded by Redburn from Neutral to Buy
  • Chewy (CHWY) upgraded by Nomura Instinet from Neutral to Buy
  • Agios Pharmaceuticals (AGIO) upgraded by Guggenheim from Neutral to Buy
  • Sanofi (SNY) upgraded by Guggenheim from Neutral to Buy
  • KKR (KKR) upgraded by BofA/Merrill from Neutral to Buy
  • Advanced Energy (AEIS) upgraded by Citi from Neutral to Buy
  • PS Business Parks (PSB) upgraded by Citi from Sell to Neutral
  • Green Brick (GRBK) upgraded by BTIG from Neutral to Buy
  • Regeneron (REGN) upgraded by Guggenheim from Neutral to Buy
[hana-code-insert name=’adsense-upgrades’ /]

Downgrades

Premium Content
  • Schnitzer Steel (SCHN) downgraded by Goldman Sachs from Neutral to Sell
  • Commercial Metals (CMC) downgraded by Goldman Sachs from Buy to Neutral
  • Alcoa (AA) downgraded by Goldman Sachs from Buy to Neutral
  • U.S. Steel (X) downgraded by JPMorgan from Overweight to Neutral
  • Illinois Tool Works (ITW) downgraded by Goldman Sachs from Neutral to Sell
  • Vallourec (VLOWY) downgraded by Societe Generale from Buy to Hold
  • Tatneft (OAOFY) downgraded by HSBC from Hold to Reduce
  • Valaris (VAL) downgraded by Citi from Neutral to Sell
  • Noble Corp. (NE) downgraded by Citi from Neutral to Sell
  • Brooks Automation (BRKS) downgraded by Citi from Buy to Neutral
  • Continental Resources (CLR) downgraded by Citi from Buy to Neutral
  • Concho Resources (CXO) downgraded by Citi from Buy to Neutral
  • Simon Property (SPG) downgraded by Citi from Buy to Neutral
  • Pennsylvania REIT (PEI) downgraded by Citi from Neutral to Sell
  • Sabra Health Care (SBRA) downgraded by Citi from Neutral to Sell
  • Whiting Petroleum (WLL) downgraded by Citi from Buy to Neutral
  • Anika Therapeutics (ANIK) downgraded by First Analysis from Strong Buy to Outperform
[hana-code-insert name=’MMPress’ /]

fly360

Upgrades & Downgrades provided by The Fly at http://www.thefly.com.  The Fly is a leading digital publisher of real-time financial news. Our financial market experts understand that news impacting stock prices can originate from anywhere, at any time. The Fly team scours all sources of company news, from mainstream to cutting-edge, then filters out the noise to deliver short-form stories consisting of only market moving content. Become an informed investor. Try all of TheFly’s services FREE for 14 days by clicking here.

Premium Content